Haleon plc (NYSE:HLN) Given Consensus Rating of "Buy" by Brokerages

Shares of Haleon plc (NYSE:HLN - Get Free Report) have received an average recommendation of "Buy" from the six brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $10.95.

Several analysts have recently weighed in on the company. UBS Group upgraded Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. Morgan Stanley upped their price target on Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a research report on Friday, September 20th. The Goldman Sachs Group cut Haleon from a "buy" rating to a "neutral" rating in a report on Tuesday, August 6th. Finally, Berenberg Bank started coverage on Haleon in a report on Tuesday, August 6th. They set a "buy" rating on the stock.

Haleon Stock Performance

Haleon stock traded up $0.09 during mid-day trading on Friday, hitting $9.64. 6,238,289 shares of the company's stock traded hands, compared to its average volume of 5,298,151. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The stock has a market cap of $43.64 billion, a price-to-earnings ratio of 28.10, a P/E/G ratio of 2.86 and a beta of 0.30. The firm has a 50 day simple moving average of $10.03 and a two-hundred day simple moving average of $9.37.

Institutional Investors Weigh In On Haleon

A number of large investors have recently made changes to their positions in the business. Manning & Napier Advisors LLC purchased a new position in Haleon in the 2nd quarter worth $2,833,000. Chartwell Investment Partners LLC raised its stake in Haleon by 107.8% in the 3rd quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company's stock worth $5,030,000 after acquiring an additional 246,594 shares during the last quarter. Magnetar Financial LLC purchased a new position in Haleon in the 1st quarter worth $853,000. Cetera Advisors LLC raised its stake in Haleon by 524.3% in the 1st quarter. Cetera Advisors LLC now owns 81,991 shares of the company's stock worth $696,000 after acquiring an additional 68,857 shares during the last quarter. Finally, Cetera Investment Advisers raised its stake in Haleon by 106.3% in the 1st quarter. Cetera Investment Advisers now owns 233,788 shares of the company's stock worth $1,985,000 after acquiring an additional 120,447 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.